Vitamin K Market by Type (Vitamin K1, Vitamin K2) Application (Osteoporosis, Vitamin K Dependent Clotting Factor Deficiency [VKCFD], Vitamin K Deficiency Bleeding [VKDB], Dermal Application) Form (Oral, Parental, Topical) And by Region (North America, Europe, Asia Pacific, South America, Middle East and Africa) Global Trends and Forecast from 2022 To 2029

Published on: Mar 2022
From:USD $3499.00
Number Of Pages:103

Please Choose License Type

Single User

Team User

Corporate License

Request a Sample

INTERESTED IN THIS RESEARCH?

Contact our analysts for inquiries, samples, and expert insights.

Market Size	CAGR	Dominating Region
USD 1443.68 Million	8.1%	North America

By Type	By Application	By Regions
Vitamin K1 Vitamin K2	Osteoporosis VKCFD VKDB Dermal Application	North America Europe Asia Pacific South America Middle East And Africa

5/5 - (11 votes)

Vitamin K Market Overview

The global vitamin k market size is projected to reach USD 1443.68 Million by 2029 from USD 716.21

Million in 2020, at a CAGR of 8.1% from 2022 to 2029.

Vitamin K, a fat-soluble micronutrient crucial for blood clotting, comprises two primary subtypes: phylloquinone (K1) and menaquinone (MK-n). Its significance extends to bone health maintenance and osteoporosis prevention.

The vitamin K market anticipates substantial growth driven by escalating demands for vitamin supplements, supported by extensive clinical evidence highlighting their pivotal role in overall health, particularly bone health. Various products such as pharmaceutical-grade injections, oral supplements, fortified foods, and dietary supplements contribute to this market surge.

Vitamin K Market | Exactitude Consultancy

Lifestyle shifts and dietary alterations contributing to vitamin K deficiencies in both developed and developing nations will further propel industry expansion. Sedentary lifestyles and unhealthy dietary habits predispose individuals to chronic conditions linked to vitamin deficiencies. Menadione and phytonadione, essential fat-soluble compounds, facilitate teeth and bone development, along with blood clotting regulation. Consequently, individuals with coagulation disorders induced by sedentary lifestyles and poor dietary habits are advised to incorporate menadione and phytonadione supplements into their daily regimens, fostering market growth.

Osteoporosis, a bone ailment increasing susceptibility to fractures, presents a significant health concern. Data from the Bone Health and Osteoporosis Foundation reveals its impact on approximately 10 million Americans, with an additional 44 million exhibiting low bone density, elevating fracture risks. A staggering 54 million Americans, half of adults aged 50 and older, face heightened fracture susceptibility due to osteoporosis. This underscores the imperative for heightened awareness and prioritization of bone health.

Vitamin K Market Segment Analysis

The vitamin k market is divided into three categories based on product type: vitamin k1, vitamin k2. Over the course of the study, the vitamin K1 segment is expected to rise by roughly 8%. Vitamin K1 is a cofactor in bone growth and has an important role in a variety of health activities. Phytonadione, which is critical for the incorporation of calcium phosphates in bones, is required for the production of osteocalcin. Vitamin K1 also has therapeutic potential and plays an important function in preventing vitamin K insufficiency. Vitamin K1 is available in a variety of dose forms, including injections, powders, and pills, to make it easier for patients to take. The aforementioned factors will help the vitamin K market grow in the future years. The vitamin K2 market is expected to increase significantly in the following years. Increased use of vitamin K2 in coronary heart disease, stroke, and other cardiac illnesses has resulted in profitable growth. The majority of vitamin K2 sources, such as fermented foods and animal liver, are insufficient to provide the daily dietary requirement of vitamin K2. Vitamin K2 aids in blood flow restoration and reduces the risk of high blood pressure and pulmonary embolism. As a result, demand for vitamin K2 drugs is expected to stay high over the predicted period.

The market is divided into osteoporosis, VKCFD, VKDB, dermal application based on application. Osteoporosis is dominating the segment of vitamin k market. Millions of individuals worldwide are affected by osteoporosis, which results in a lower quality of life, a significant financial burden, and a longer disability-adjusted life span. It is caused by a vitamin K deficiency. As a result, it is required for the gamma-carboxylation of osteocalcin, which helps to preserve bone mass. Furthermore, recent researches have shown that vitamin K has a beneficial effect in the treatment of osteoporosis and fractures in postmenopausal women. As a result, rising osteoporosis prevalence will boost demand during the predicted period. VKCFD is an autosomal recessive condition that affects consanguineous married couples frequently. Furthermore, persons with VKCFD experience symptoms like severe bleeding, easy bruising, minor hearing loss, and skeletal abnormalities. Vitamins are important in the therapy of VKCFD and are provided to patients as tablets or injectable to assist reduce symptoms of hereditary combined deficiency. As a result, efficient treatment for VKCFD achieved with vitamin K will boost segmental expansion in the near future.

The market is divided into form such as oral, parental, topical. Oral segment is dominating the vitamin k market and is anticipated to witness tremendous growth in coming years. The oral route of administration is the preferred method of administration because it is the most effective and safe. Because oral formulations have a high level of medication stability, they are in high demand. Furthermore, the benefits of the oral route, such as convenience of administration, non-invasiveness, and cost-effectiveness, will propel the segment forward. Parental segment is expected to grow faster in forecast period. Parenteral formulations avoid the first-pass metabolism that causes medication degradation in the liver. Improved bioavailability of the medicine allows for faster delivery of the required dose to the targeted site of action. The aforementioned factors will propel the vitamin K industry to new heights.

Vitamin K Market Key Players

The major players operating in the global vitamin k industry include Amphastar Pharmaceuticals, BASF, DSM, Kappa Bioscience, Livealth Biopharma, NattoPharma, NOW Foods, Pfizer, Solgar. These industry players are implementing several strategies such as product launches, collaborations, mergers and acquisitions to sustain industry competition and capture higher market share.

Tokyo, Japan, September 29, 2021 – BASF will participate at Health Ingredients Japan (HIJ) 2021 held from October 06 to 08 at the Tokyo Big Sight Exhibition Center, West Hall 1, booth 148. HIJ is a leading platform in Japan for the showcase of functional foods, supplements, and nutraceuticals.

Who Should Buy? Or Key stakeholders

Medical Technology Companies
Environment, Health and Safety Professionals
Research Organizations
Pharmaceutical companies
Others

Key Takeaways:

The global vitamin k market size is projected to grow at a CAGR of 8.1% during the forecast period.
Vitamin K1 is a cofactor in bone growth and has an important role in a variety of health activities. Phytonadione, which is critical for the incorporation of calcium phosphates in bones, is required for the production of osteocalcin.
Based on application, Osteoporosis is dominating the segment of vitamin k market. Millions of individuals worldwide are affected by osteoporosis, which results in a lower quality of life, a significant financial burden, and a longer disability-adjusted life span.
North America is expected to hold the largest share of the global vitamin k market. The rising frequency of vitamin K-related disorders such newborn hemorrhage, osteoporosis, arthritis, diabetes, and vascular calcification would have a significant positive impact on the industry’s growth.
One major trend in the vitamin K market is the increasing recognition of its role in promoting bone and cardiovascular health, driving demand for supplements and fortified food products.

Vitamin K Market Regional Analysis

Geographically, the vitamin k market is segmented into North America, South America, Europe, APAC and MEA.

North America: includes the US, Canada, Mexico
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

North America is expected to hold the largest share of the global vitamin k market. The rising frequency of vitamin K-related disorders such newborn hemorrhage, osteoporosis, arthritis, diabetes, and vascular calcification would have a significant positive impact on the industry’s growth. Sedentary lifestyles, bad food consumption, and a lack of exercise will activate the risk factors connected with the diseases indicated above, boosting regional expansion.

Key Market Segments: Vitamin K Market

Vitamin K Market By Type, 2020-2029, (USD Million)

Vitamin K1
Vitamin K2

Vitamin K Market By Application, 2020-2029, (USD Million)

Osteoporosis
VKCFD
VKDB
Dermal Application

Vitamin K Market By Form, 2020-2029, (USD Million)

Oral
Parental
Topical

Vitamin K Market By Regions, 2020-2029, (USD Million)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important Countries In All Regions Are Covered

Key Question Answered

What is the current scenario of the global vitamin k market?
What are the emerging technologies for the development of vitamin k devices?
What are the historical size and the present size of the market segments and their future potential?
What are the major catalysts for the market and their impact during the short, medium, and long terms?
What are the evolving opportunities for the players in the market?
Which are the key regions from the investment perspective?
What are the key strategies being adopted by the major players to up their market shares?

Introduction
1. Market Definition
2. Market Segmentation
3. Research Timelines
4. Assumptions and Limitations
Research Methodology
1. Data Mining
  1. Secondary Research
  2. Primary Research
  3. Subject-Matter Experts’ Advice
2. Quality Checks
  1. Final Review
3. Data Triangulation
  1. Bottom-Up Approach
  2. Top-Down Approach
  3. Research Flow
4. Data Sources
Executive Summary
Market Overview
1. Global Vitamin K Market Outlook
  1. Market Drivers
  2. Market Restraints
  3. Market Opportunities
2. Impact of Covid-19 On Global Vitamin K Market
Global Vitamin K Market by Type, (USD Million)
1. Vitamin K1
2. Vitamin K2
Global Vitamin K Market by Application, (USD Million)
1. Osteoporosis
2. VKCFD
3. VKDB
Global Vitamin K Market by Form, (USD Million)
1. Oral
2. Parental
3. Topical
Global Vitamin K Market by Region, (USD Million)
1. Introduction
2. Asia-Pacific
  1. China
  2. India
  3. Japan
  4. South Korea
  5. Australia
  6. South-East Asia
  7. Rest of Asia-Pacific
3. North America
  1. United States
  2. Canada
  3. Mexico
4. Europe
  1. Germany
  2. United Kingdom
  3. France
  4. Italy
  5. Spain
  6. Russia
  7. Rest of Europe
5. South America
  1. Brazil
  2. Argentina
  3. Colombia
  4. Rest of South America
6. Middle East and Africa
  1. UAE
  2. Saudi Arabia
  3. South Africa
  4. Rest of Middle East and Africa

Company Profiles*

(Business Overview, Company Snapshot, FORMs Offered, Recent Developments)

Amphastar Pharmaceuticals
BASF
DSM
Kappa Bioscience
Livealth Biopharma
NattoPharma
NOW Foods
Pfizer
Solgar

*The Company List Is Indicative

LIST OF TABLES

Table 1 GLOBAL VITAMIN K MARKET BY TYPE (USD MILLIONS)

Table 2 GLOBAL VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 3 GLOBAL VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 4 GLOBAL VITAMIN K MARKET BY REGION (USD MILLIONS) 2020-2029

Table 5 US VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 6 US VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 7 US VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 8 CANADA VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 9 CANADA VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 10 CANADA VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 11 MEXICO VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 12 MEXICO VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 13 MEXICO VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 14 BRAZIL VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 15 BRAZIL VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 16 BRAZIL VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 17 ARGENTINA VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 18 ARGENTINA VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 19 ARGENTINA VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 20 COLOMBIA VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 21 COLOMBIA VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 22 COLOMBIA VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 23 REST OF SOUTH AMERICA VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 24 REST OF SOUTH AMERICA VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 25 REST OF SOUTH AMERICA VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 26 INDIA VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 27 INDIA VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 28 INDIA VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 29 CHINA VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 30 CHINA VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 31 CHINA VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 32 JAPAN VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 33 JAPAN VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 34 JAPAN VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 35 SOUTH KOREA VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 36 SOUTH KOREA VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 37 SOUTH KOREA VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 38 AUSTRALIA VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 39 AUSTRALIA VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 40 AUSTRALIA VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 41 SOUTH-EAST ASIA VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 42 SOUTH-EAST ASIA VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 43 SOUTH-EAST ASIA VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 44 REST OF ASIA PACIFIC VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 45 REST OF ASIA PACIFIC VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 46 REST OF ASIA PACIFIC VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 47 GERMANY VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 48 GERMANY VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 49 GERMANY VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 50 UK VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 51 UK VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 52 UK VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 53 FRANCE VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 54 FRANCE VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 55 FRANCE VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 56 ITALY VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 57 ITALY VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 58 ITALY VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 59 SPAIN VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 60 SPAIN VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 61 SPAIN VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 62 RUSSIA VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 63 RUSSIA VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 64 RUSSIA VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 65 REST OF EUROPE VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 66 REST OF EUROPE VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 67 REST OF EUROPE VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 68 UAE VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 69 UAE VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 70 UAE VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 71 SAUDI ARABIA VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 72 SAUDI ARABIA VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 73 SAUDI ARABIA VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 74 SOUTH AFRICA VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 75 SOUTH AFRICA VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 76 SOUTH AFRICA VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

Table 77 REST OF MIDDLE EAST AND AFRICA VITAMIN K MARKET BY TYPE (USD MILLIONS) 2020-2029

Table 78 REST OF MIDDLE EAST AND AFRICA VITAMIN K MARKET BY APPLICATION (USD MILLIONS) 2020-2029

Table 79 REST OF MIDDLE EAST AND AFRICA VITAMIN K MARKET BY FORM (USD MILLIONS) 2020-2029

LIST OF FIGURES

FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL DECORATIVE COATINGS MARKET BY RESIN TYPE, USD MILLION, 2020-2029

FIGURE 9 GLOBAL DECORATIVE COATINGS MARKET BY APPLICATION, USD MILLION, 2020-2029

FIGURE 10 GLOBAL DECORATIVE COATINGS MARKET BY USER TYPE, USD MILLION, 2020-2029

FIGURE 11 GLOBAL DECORATIVE COATINGS MARKET BY TECHNOLOGY, USD MILLION, 2020-2029

FIGURE 12 GLOBAL DECORATIVE COATINGS MARKET BY COATING TYPE, USD MILLION, 2020-2029

FIGURE 13 GLOBAL DECORATIVE COATINGS MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 14 PORTER’S FIVE FORCES MODEL

FIGURE 15 GLOBAL DECORATIVE COATINGS MARKET BY RESIN TYPE, USD MILLION, 2020-2029

FIGURE 16 GLOBAL DECORATIVE COATINGS MARKET BY APPLICATION 2020

FIGURE 17 GLOBAL DECORATIVE COATINGS MARKET BY USER TYPE, USD MILLION, 2020-2029

FIGURE 18 GLOBAL DECORATIVE COATINGS MARKET BY COATING TYPE, USD MILLION, 2020-2029

FIGURE 19 GLOBAL DECORATIVE COATINGS MARKET BY TECHNOLOGY, USD MILLION, 2020-2029

FIGURE 20 DECORATIVE COATINGS MARKET BY REGION 2020

FIGURE 21 MARKET SHARE ANALYSIS

FIGURE 19 AMPHASTAR PHARMACEUTICALS: COMPANY SNAPSHOT

FIGURE 20 BASF: COMPANY SNAPSHOT

FIGURE 21 DSM: COMPANY SNAPSHOT

FIGURE 22 KAPPA BIOSCIENCE: COMPANY SNAPSHOT

FIGURE 23 LIVEALTH BIOPHARMA: COMPANY SNAPSHOT

FIGURE 24 NATTOPHARMA: COMPANY SNAPSHOT

FIGURE 25 NOW FOODS: COMPANY SNAPSHOT

FIGURE 26 PFIZER: COMPANY SNAPSHOT

FIGURE 27 SOLGAR: COMPANY SNAPSHOT

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Complete pre and post sales
support.

Safe & Secure

Complete secure payment
process.

INTERESTED IN THIS RESEARCH?

REPORT OUTLOOK

SCOPE OF THE REPORT